---
title: "Cingulate Inc. (CING.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/CING.US.md"
symbol: "CING.US"
name: "Cingulate Inc."
industry: "Pharmaceuticals"
datetime: "2026-06-13T17:56:59.999Z"
locales:
  - [en](https://longbridge.com/en/quote/CING.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/CING.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/CING.US.md)
---

# Cingulate Inc. (CING.US)

## Company Overview

Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products using its drug delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company’s lead product candidate is CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials for the treatment of ADHD in children, adolescents, and adults. It also develops CTx-2103 (buspirone), which is in a formulation stage for the treatment of anxiety. In addition, the company plans to initiate a clinical plan for CTx-1302 (dextroamphetamine) to treat ADHD.

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Exchange | US Market |
| Website | [www.cingulate.com](https://www.cingulate.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: 
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 1970-01-01T00:00:00.000Z

**Overall:  (0.00)**

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -2.14 | 134 | - | - | - |
| PB | 3.17 | 116 | 14.60 | 4.25 | 3.58 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-06-07T04:00:00.000Z

Total Analysts: **6**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 3 | 50% |
| Overweight | 1 | 17% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 4.88 |
| Highest Target | 52.00 |
| Lowest Target | 8.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/CING.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/CING.US/norm.md)
- [Related News](https://longbridge.com/en/quote/CING.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/CING.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**